Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04078841 · ClinicalTrials.gov registry record · Phase 1
Treating Post-Lyme Disease Syndrome With Acetogenins
A Phase 1 study, sponsored by Optimal Health Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT04078841: Completed Phase 1 study, sponsored by Optimal Health Research.
NCT04078841 is a Phase 1 study that has completed, run by Optimal Health Research. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04078841, a Phase 1 study, has completed, sponsored by Optimal Health Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
Primary Outcome
Western Blot showing "negative"
Interventions
- DIETARY_SUPPLEMENT ReaLife+ (RLP)
- OTHER Inert Brown powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2020-01-30 |
| Phase | Phase 1 |
What the finished NCT04078841 record still lists
NCT04078841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which ReaLife+ (RLP) is the first listed.
NCT04078841 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04078841 about?
NCT04078841 is a clinical study titled "Treating Post-Lyme Disease Syndrome With Acetogenins". To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
What is the current status of trial NCT04078841?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2019-07-01. Estimated completion is 2020-01-30.
What interventions are being tested in trial NCT04078841?
The interventions under investigation include: ReaLife+ (RLP) (DIETARY_SUPPLEMENT), Inert Brown powder (OTHER).
Who is sponsoring clinical trial NCT04078841?
This trial is sponsored by Optimal Health Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04078841's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI